Hsp90

Hsp90

For Philadelphia chromosome-positive ALL sufferers, it is strongly recommended to change the therapeutic method of tyrosine-kinase-inhibitor-based treatment in conjunction with steroids instead of multi-agent chemotherapy [58,59]

For Philadelphia chromosome-positive ALL sufferers, it is strongly recommended to change the therapeutic method of tyrosine-kinase-inhibitor-based treatment in conjunction with steroids instead of multi-agent chemotherapy

Hsp90

d The concordance of transcriptional signatures between prior and current BPH research

d The concordance of transcriptional signatures between prior and current BPH research. GEO beneath the accession “type”:”entrez-geo”,”attrs”:”text”:”GSE123111″,”term_id”:”123111″GSE123111 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=”type”:”entrez-geo”,”attrs”:”text”:”GSE123111″,”term_id”:”123111″GSE123111). Abstract Benign prostatic hyperplasia (BPH), a non-malignant